Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M El Sahly

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 29, 2013
Mycobacterium tuberculosis bacteraemia: experience from a non-endemic urban centreH M El Sahly, L D Teeter, J M Musser, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2000
Spectrum of clinical illness in hospitalized patients with "common cold" virus infectionsH M El-Sahly, R L Atmar, W P Glezen, et al.
The Journal of Infectious Diseases|January 3, 2001
Epidemiologic differences between United States- and foreign-born tuberculosis patients in Houston, TexasH M El Sahly, G J Adams, H Soini, et al.
Vaccine|November 3, 2009
Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons > or =65 years oldW A Keitel, J J Treanor, H M El Sahly, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 14, 2004
Recurrent tuberculosis in Houston, Texas: a population-based studyH M El Sahly, J A Wright, H Soini, et al.
Clinical and Vaccine Immunology : CVI|August 13, 2010
Safety and immunogenicity of a recombinant nonglycosylated erythrocyte binding antigen 175 Region II malaria vaccine in healthy adults living in an area where malaria is not endemicH M El Sahly, S M Patel, R L Atmar, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 18, 2002
5' dinucleotide repeat polymorphism of NRAMP1 and susceptibility to tuberculosis among Caucasian patients in Houston, TexasX Ma, S Dou, J A Wright, et al.
Vaccine|July 2, 2009
Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humansH M El Sahly, R L Atmar, S M Patel, et al.
Vaccine|September 14, 2019
A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic areaW A Keitel, G E Potter, D Diemert, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 29, 2013
Mycobacterium tuberculosis bacteraemia: experience from a non-endemic urban centreH M El Sahly, L D Teeter, J M Musser, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2000
Spectrum of clinical illness in hospitalized patients with "common cold" virus infectionsH M El-Sahly, R L Atmar, W P Glezen, et al.
The Journal of Infectious Diseases|January 3, 2001
Epidemiologic differences between United States- and foreign-born tuberculosis patients in Houston, TexasH M El Sahly, G J Adams, H Soini, et al.
Vaccine|November 3, 2009
Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons > or =65 years oldW A Keitel, J J Treanor, H M El Sahly, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 14, 2004
Recurrent tuberculosis in Houston, Texas: a population-based studyH M El Sahly, J A Wright, H Soini, et al.
Clinical and Vaccine Immunology : CVI|August 13, 2010
Safety and immunogenicity of a recombinant nonglycosylated erythrocyte binding antigen 175 Region II malaria vaccine in healthy adults living in an area where malaria is not endemicH M El Sahly, S M Patel, R L Atmar, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 18, 2002
5' dinucleotide repeat polymorphism of NRAMP1 and susceptibility to tuberculosis among Caucasian patients in Houston, TexasX Ma, S Dou, J A Wright, et al.
Vaccine|July 2, 2009
Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humansH M El Sahly, R L Atmar, S M Patel, et al.
Vaccine|September 14, 2019
A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic areaW A Keitel, G E Potter, D Diemert, et al.
Pageof 1